| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/2010 | EP2204171A1 Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 07/07/2010 | EP2204169A1 Granular preparation containing biguanide compound |
| 07/07/2010 | EP2204168A1 Once daily formulations of tetracyclines |
| 07/07/2010 | EP2203559A2 Combination treatment for the treatment of hepatitis c virus infection |
| 07/07/2010 | EP2203477A2 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 07/07/2010 | EP2203463A2 Antiviral agents |
| 07/07/2010 | EP2203462A2 Nucleoside phosphoramidate prodrugs |
| 07/07/2010 | EP2203459A1 Spirocyclic aminoquinolones as gsk-3 inhibitors |
| 07/07/2010 | EP2203458A2 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 07/07/2010 | EP2203457A2 Dispiro 1,2,4-trioxolane antimalarials |
| 07/07/2010 | EP2203454A1 Tricyclic heterocyclic derivatives |
| 07/07/2010 | EP2203453A1 Pyrazolo[5, 1-c] [1,2,4]triazines, methods for preparation and use thereof |
| 07/07/2010 | EP2203452A1 Pyrrolopyrimidine compounds |
| 07/07/2010 | EP2203451A2 Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives |
| 07/07/2010 | EP2203450A2 Chiral synthesis of diazepinoquinolines |
| 07/07/2010 | EP2203449A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 07/07/2010 | EP2203448A1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical |
| 07/07/2010 | EP2203447A1 Inhibitors of the interaction between mdm2 and p53 |
| 07/07/2010 | EP2203446A1 Chromenone derivatives and their use for leukotriene biosynthesis inhibition |
| 07/07/2010 | EP2203445A1 Azabicyclo ý3. 1. o¨hexyl derivatives as modulators of dopamine d3 receptors |
| 07/07/2010 | EP2203444A1 Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate |
| 07/07/2010 | EP2203443A1 Prodrugs to thyroid hormone analogs |
| 07/07/2010 | EP2203442A1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| 07/07/2010 | EP2203440A1 Inhibitors of the interaction between mdm2 and p53 |
| 07/07/2010 | EP2203439A1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones |
| 07/07/2010 | EP2203438A1 Cyanoisoquinoline |
| 07/07/2010 | EP2203437A1 Chiral cis-imidazolines |
| 07/07/2010 | EP2203436A1 Pyrazine derivatives and their use as potassium channel modulators |
| 07/07/2010 | EP2203435A2 6, 11-bridged biaryl macrolides |
| 07/07/2010 | EP2203432A1 Method of treatment |
| 07/07/2010 | EP2203431A1 Anti-infective pyrimidines and uses thereof |
| 07/07/2010 | EP2203430A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 07/07/2010 | EP2203429A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 07/07/2010 | EP2203426A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/07/2010 | EP2203424A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 07/07/2010 | EP2203423A1 Indoline compounds |
| 07/07/2010 | EP2203422A1 Phenylpyrrolidine compounds |
| 07/07/2010 | EP2203416A1 (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament |
| 07/07/2010 | EP2203415A1 (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament |
| 07/07/2010 | EP2203411A2 N-phenyl anthranilic acid derivatives and uses thereof |
| 07/07/2010 | EP2203219A1 Substituted benamidines as antibacterial agents |
| 07/07/2010 | EP2203177A1 Methods and kits for the treatment of diverticular conditions |
| 07/07/2010 | EP2203175A1 Preparation for wound healing and prevention of bandage adhesion to the wound, containing chitosan-glucan |
| 07/07/2010 | EP2203173A2 Means and methods for counteracting muscle disorders |
| 07/07/2010 | EP2203170A1 Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
| 07/07/2010 | EP2203169A1 Glycemic control, diabetes treatment, and other treatments with acetyl cholinesterase inhibitors |
| 07/07/2010 | EP2203168A2 Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 07/07/2010 | EP2203167A1 Compound and use thereof in the treatment of amyloidosis |
| 07/07/2010 | EP2203165A2 Ophthalmic formulation containing paracetamol |
| 07/07/2010 | EP2203164A2 Method and apparatus for diagnoses of hemangiosarcoma in mammals |
| 07/07/2010 | EP2203163A1 Titration package for neramexane and its use in the treatment of an inner ear disorder |
| 07/07/2010 | EP2203160A1 Pharmacological adjunctive treatment associated with glaucoma filtration surgery |
| 07/07/2010 | EP2203158A2 Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide |
| 07/07/2010 | EP2203156A2 Candesartan cilexetil |
| 07/07/2010 | EP2203070A2 Pomegranate extracts, nutritional products containing them and their uses |
| 07/07/2010 | EP2203068A1 Methods of treating gastrointestinal disorders independent of the intake of food |
| 07/07/2010 | EP2203061A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 07/07/2010 | EP2203060A1 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase |
| 07/07/2010 | EP2203059A1 Method of treating inherited severe neutropenia |
| 07/07/2010 | EP2203057A1 Method and compositions for treatment or prevention of inflammatory conditions |
| 07/07/2010 | EP2203056A1 Controlled release pharmaceutical compositions |
| 07/07/2010 | EP2203055A1 1-methyl nicotinamide and derivatives for treatment of gastric injury |
| 07/07/2010 | EP2203051A1 Octahydropentalene compounds as chemokine receptor antagonists |
| 07/07/2010 | EP2203050A1 Use of r(+)-n-propargyl-1-aminoindan to treat or prevent hearing loss |
| 07/07/2010 | EP2040674B1 Cationic liposomal preparations for the treatment of rheumatoid arthritis |
| 07/07/2010 | EP2029529B1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/07/2010 | EP2010921B1 Method for diagnosing cardiovascular diseases |
| 07/07/2010 | EP1940817B1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 07/07/2010 | EP1873153B1 3-azetidinecarboxylic acid derivatives for use as immunosuppressants |
| 07/07/2010 | EP1861380B1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists |
| 07/07/2010 | EP1858861B1 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines |
| 07/07/2010 | EP1765829B1 Tricyclic compounds and their use as mglur1 antagonists |
| 07/07/2010 | EP1708692B1 Dichloroacetate in combination with an inotrope for cardioprotection |
| 07/07/2010 | EP1670785B1 Salts and polymorphs of a pyrrole-substituted indolinone compound |
| 07/07/2010 | EP1663217B1 Solid dispersions comprising tacrolimus |
| 07/07/2010 | EP1597244B1 Ethynyl derivatives serving as factor xa inhibitors |
| 07/07/2010 | EP1491537B1 Hydroxymorpholinone derivative and medicinal use thereof |
| 07/07/2010 | EP1487806B1 4-anilino quinazoline derivatives as antiproliferative agents |
| 07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
| 07/07/2010 | EP1455601B1 Composition for promotion of bone growth and maintenance of bone health |
| 07/07/2010 | EP1446126B1 Coated particulate cefuroxime axetil compositions |
| 07/07/2010 | EP1392301B1 Prevention of addiction in pain management with gamma vinyl gaba |
| 07/07/2010 | EP1383919B1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 07/07/2010 | EP1286669B1 Compositions for prevention of ulcers in horses |
| 07/07/2010 | EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 07/07/2010 | CN201522180U Sodium heparin drying device |
| 07/07/2010 | CN1942469B Condensed pyridine derivatives useful as A28 adenosine receptor antagonists |
| 07/07/2010 | CN1905871B N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine 2 methansulfonic acid salt |
| 07/07/2010 | CN1859918B Use of hyaluronic acid for treating acute and overuse sprain and strain |
| 07/07/2010 | CN1845894B Phenoxiacetic acid derivatives |
| 07/07/2010 | CN1784221B Compositions for affecting weight loss |
| 07/07/2010 | CN1674863B Antiaging composition |
| 07/07/2010 | CN101772511A Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof |
| 07/07/2010 | CN101772507A proteasome inhibitors |
| 07/07/2010 | CN101772506A macrocycles and their uses |
| 07/07/2010 | CN101772504A substituted bicyclolactam compounds |
| 07/07/2010 | CN101772502A (7H-pyrr0l0 [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation |
| 07/07/2010 | CN101772501A Heterocyclic compounds and use thereof as ERK inhibitors |
| 07/07/2010 | CN101772500A Imidazopyrazines as protein kinase inhibitors |
| 07/07/2010 | CN101772499A Tricyclic N-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |